Prescription Treatments for Rosacea

PROTOPIC Ointment is not for oral use. Oral ingestion of PROTOPIC Ointment may lead to adverse effects associated with systemic administration of tacrolimus. If oral ingestion occurs, medical advice should be sought.

The most common side effects are stinging, burning, or itching, which generally occur early in treatment and typically lessen as skin heals. Protopic may be associated with an increased risk of certain skin infections. When using Protopic, avoid direct sunlight, tanning salons, and phototherapy, and don't cover the skin being treated with bandages, dressings, or wraps.

Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding.


DIFFERIN (adapalene gel) Gel 0.1% is a topical retinoid analogue indicated for the treatment of acne vulgaris.

Used for the topical treatment of acne vulgaris, DIFFERIN Gel significantly reduces both inflammatory and non-inflammatory lesions. In clinical trials, DIFFERIN Gel has proven to be as effective as tretinoin 0.025%, and with low cutaneous irritation.

Formulated specifically for the special needs of acne sufferers, DIFFERIN Gel is oil free and alcohol free. Acne patients will appreciate its non-greasy feel.

Although mild dryness, erythema, burning or pruritus was experienced by 10% to 40% of patients; 20% of patients experienced pruritus and burning immediately after application. If a reaction suggesting sensitivity or chemical irritation occurs, use of the medication should be discontinued. Exposure to sunlight, including sunlamps, should be minimized during the use of adapalene. Patients, who normally experience high levels of sun exposure, and those with inherent sensitivity to sun, should be warned to exercise caution. Use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided. Weather extremes, such as wind or cold, also may be irritating to patients under treatment with adapalene.

Avoid contact with the eyes, lips, angles of the nose, and mucous membranes. The product should not be applied to cuts, abrasions, eczematous skin, or sunburned skin.

As DIFFERIN Gel has the potential to produce local irritation in some patients, concomitant use of other potentially irritating topical products (medicated or abrasive soaps and cleansers, soaps and cosmetics that have a strong drying effect and products with high concentrations of alcohol, astringents, spices, or lime) should be approached with caution. Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with DIFFERIN® Gel. If these preparations have been used, it is advisable not to start therapy with DIFFERIN® Gel until the effects of such preparations in the skin have subsided.

Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding.

CAPEXTM Hair and Scalp Shampoo

CAPEXTM Hair and Scalp Shampoo (fluocinolone acetonide) Topical Shampoo, 0.01%

CapexTM Shampoo (fluocinolone acetonide) topical shampoo, 0.01% is a proven, effective treatment that works at the source to stop severe dandruff.

CapexTM Shampoo's unique steroid delivery system allows optional hair saturation and ensures patients receive uniform therapy. Few side effects, lack of odor and its quick, easy application makes CapexTM Shampoo popular with patients.

CapexTM Shampoo is in the low to medium range of potency as compared with other topical corticosteroids.

Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticoid insufficiency after withdrawal of treatment. Manifestations of Cushing's syndrome, hyperglycemia and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.

If irritation develops, CapexTM Shampoo should be discontinued and appropriate therapy instituted. Allergic contact dermatitis with corticosteroids is usually diagnosed by a failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing.

If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of CapexTM Shampoo should be discontinued until the infection has been adequately controlled.


DESOWEN (desonide ) Lotion,ointment,or cream.

DESOWEN is a low-potency, topical corticosteroid. The active ingredient is desonide, a non-halogenated (non-fluorinated, non-chlorinated) corticosteroid. Each gram contains 0.5 mg of desonide.

DESOWEN contains no isopropyl alcohol, an ingredient that can cause severe stinging and burning.

DESOWEN is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Generalized eczema, contact dermatitis, and seborrheic dermatitis are examples of conditions that may be effectively treated with DESOWEN Lotion.

In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide was approximately 8%. These were: stinging and burning approximately 3%, irritation, contact dermatitis, condition worsened, peeling of the skin, itching, intense transient erythema, and dryness/scaliness, each less than 2%.

As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.

Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding.

Page 1 2 3